CME Group Upgraded To Neutral By JPMorgan

Mani

Published onJune 25, 2013

Updated on May 13, 2021

CME Group Inc (NASDAQ:CME) was upgraded by JPMorgan Chase & Co. (NYSE:JPM)’s research analysts from an ‘underweight’ rating to a ‘neutral’ rating.

Table of Contents

Kenneth B. Worthington and team, however, don’t recommend CME Group Inc (NASDAQ:CME) at the current price, given the potential for volatility to stabilize and for volumes to normalize.

CME Group Inc (NASDAQ:CME) is the world’s leading and most diverse derivatives marketplace offering the widest range of futures and options products for risk management.

CME Group’s Volumes Surge

JPMorgan Chase & Co. (NYSE:JPM) analysts feel CME Group Inc (NASDAQ:CME)’s leading interest rate futures business is...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mani

Mani is a Senior Financial Consultant. He has worked in Senior Management role in large banking, financial and information technology organizations. He has provided solutions for major banking and securities firms across the globe in the area of retail, corporate and investment banking. He holds MBA (Finance) and Professional Management Accounting Qualifications. His hobbies are tracking global financial developments and watching sports

CME Group Upgraded To Neutral By JPMorgan

CME Group’s Volumes Surge

Login required to continue reading.

Get Your Business News